Facility Features
- 725 m² GMP standards vaccine/drug production area
- 482 m² clean room
- 589 m² laboratory area
- A pilot scale production facility with a total area of 3,585 m²
MEDIBIYO aims to increase Turkey's research and production capacity in biotechnology, accelerate domestic and national drug/vaccine development processes, and enhance the country's competitiveness in this field. With its modern infrastructure, expert staff, and innovative approach, MEDIBIYO is ready to make significant contributions to Turkey's future in biotechnology.
MEDIBIYO is an innovative research and production center aiming to increase Turkey's biotechnological drug and vaccine development capacity. Spread over an area of 3585 m², this modern facility houses all the necessary infrastructure for the development and production of biotechnological drug/vaccine candidates, starting from the cell level.
Pilot scale bioproduction, research and analysis capabilities based on single-use technologies.
Opportunity to develop, test and validate parameters before large-scale production.
Single-use production capacity up to 50 liters.
Customized solutions for the entire facility or specific areas of interest.
Comprehensive training programs for industry professionals.
This website has been produced with the financial support of the European Union and the Republic of Türkiye. The consortium led by TUBITAK Marmara Research Center is responsible for the content of the website, and it cannot be interpreted in any way as reflecting the views of the European Union and the Republic of Türkiye.
